Gaël Debauve

UCB Pharma S.A.

Gaël joined UCB in July 2011 taking up the position of Head of Bioassay Development Group. The Bioassay team aims to develop and validate CMC biological potency assays from phase I readiness to phase III and beyond. In 2007, Gaël completed a Ph.D. in Biomedical Sciences at the University of Mons (Belgium). Then, he joined SGS, a contract laboratory organization, for four years where he headed the Biopharmaceutical QC department. In 2010, Gaël took an associate professor position at the University of Mons where he lectures on quality standards in the pharmaceutical industry. In 2011, he completed a master’s degree in management at the Louvain School of Management (UCL, Belgium). Since 2017, Gaël is providing his bioassay expertise to the EDQM MAb working party as ad-hoc specialist.